Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

393 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neuropsychiatric prodromes and symptom timings in relation to disease onset and/or flares in SLE: results from the mixed methods international INSPIRE study.
Sloan M, Bourgeois JA, Leschziner G, Pollak TA, Pitkanen M, Harwood R, Bosley M, Bortoluzzi A, Andreoli L, Diment W, Brimicombe J, Ubhi M, Barrere C, Naughton F, Gordon C, D'Cruz D. Sloan M, et al. Among authors: d cruz d. EClinicalMedicine. 2024 May 20;73:102634. doi: 10.1016/j.eclinm.2024.102634. eCollection 2024 Jul. EClinicalMedicine. 2024. PMID: 39429812 Free PMC article.
Prevalence and identification of neuropsychiatric symptoms in systemic autoimmune rheumatic diseases: an international mixed methods study.
Sloan M, Wincup C, Harwood R, Pollak TA, Massou E, Bosley M, Pitkanen M, Zandi MS, Leschziner G, Barrere C, Ubhi M, Andreoli L, Brimicombe J, Diment W, Jayne D, Gordon C, Naughton F, D'Cruz D. Sloan M, et al. Rheumatology (Oxford). 2024 May 2;63(5):1259-1272. doi: 10.1093/rheumatology/kead369. Rheumatology (Oxford). 2024. PMID: 37491699 Free PMC article.
Attribution of neuropsychiatric symptoms and prioritisation of evidence in the diagnosis of neuropsychiatric lupus: mixed methods analysis of patient and clinician perspectives from the international INSPIRE study.
Sloan M, Andreoli L, Zandi MS, Harwood R, Pitkanen M, Sloan S, Barrere C, Massou E, Wincup C, Bosley M, Naughton F, Ubhi M, Jayne D, Leschziner G, Brimicombe J, Diment W, Middleton K, Gordon C, D'Cruz D, Pollak TA. Sloan M, et al. Rheumatology (Oxford). 2023 Dec 18:kead685. doi: 10.1093/rheumatology/kead685. Online ahead of print. Rheumatology (Oxford). 2023. PMID: 38105443
Long-Term Effectiveness of Benralizumab in Eosinophilic Granulomatosis With Polyangiitis.
Nanzer AM, Maynard-Paquette AC, Alam V, Green L, Thomson L, Lam J, Fernandes M, Roxas C, d'Ancona G, Hearn A, Gates J, Agarwal S, Kent BD, Fernando M, D'Cruz DP, Hopkins C, Ismail TF, Dhariwal J, Jackson DJ. Nanzer AM, et al. J Allergy Clin Immunol Pract. 2024 Mar;12(3):724-732. doi: 10.1016/j.jaip.2024.01.006. Epub 2024 Jan 9. J Allergy Clin Immunol Pract. 2024. PMID: 38211889
Development of an algorithm for IgG4-related disease management.
Orozco-Gálvez O, Fernández-Codina A, Lanzillotta M, Ebbo M, Schleinitz N, Culver EL, Rebours V, D'Cruz DP, Della-Torre E, Martínez-Valle F. Orozco-Gálvez O, et al. Autoimmun Rev. 2023 Mar;22(3):103273. doi: 10.1016/j.autrev.2023.103273. Epub 2023 Jan 20. Autoimmun Rev. 2023. PMID: 36682575 Review.
393 results